血液癌治療の世界市場2019-2023...市場調査レポートについてご紹介

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: PIPELINE
PART 07: MARKET SEGMENTATION BY TYPE
• Market segmentation by type
• Comparison by type
• Leukemia – Market size and forecast 2018-2023
• Lymphoma – Market size and forecast 2018-2023
• Myeloma – Market size and forecast 2018-2023
• Market opportunity by type
PART 08: CUSTOMER LANDSCAPE
PART 09: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America – Market size and forecast 2018-2023
• Europe – Market size and forecast 2018-2023
• Asia – Market size and forecast 2018-2023
• ROW – Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 10: DECISION FRAMEWORK
PART 11: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 12: MARKET TRENDS
PART 13: VENDOR LANDSCAPE
• Overview
• Landscape disruption
• Competitive scenario
PART 14: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Bristol-Myers Squibb Company
• F. Hoffmann-La Roche Ltd
• Johnson & Johnson Services, Inc.
• Novartis AG
• Takeda Pharmaceutical Company Limited
PART 15: APPENDIX
• Research methodology
• List of abbreviations
PART 16: EXPLORE TECHNAVIO


Exhibit 01: Global oncology therapeutics market
Exhibit 02: Segments of global oncology therapeutics market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition – Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition – Five forces 2018
Exhibit 17: Global blood cancer therapeutics market pipeline: Overview
Exhibit 18: Global blood cancer therapeutics market pipeline: Overview
Exhibit 19: Type – Market share 2018-2023 (%)
Exhibit 20: Comparison by type
Exhibit 21: Leukemia – Market size and forecast 2018-2023 ($ millions)
Exhibit 22: Leukemia – Year-over-year growth 2019-2023 (%)
Exhibit 23: Lymphoma – Market size and forecast 2018-2023 ($ millions)
Exhibit 24: Lymphoma – Year-over-year growth 2019-2023 (%)
Exhibit 25: Myeloma – Market size and forecast 2018-2023 ($ millions)
Exhibit 26: Myeloma – Year-over-year growth 2019-2023 (%)
Exhibit 27: Market opportunity by type
Exhibit 28: Customer landscape
Exhibit 29: Market share by geography 2018-2023 (%)
Exhibit 30: Geographic comparison
Exhibit 31: North America – Market size and forecast 2018-2023 ($ millions)
Exhibit 32: North America – Year-over-year growth 2019-2023 (%)
Exhibit 33: Top 3 countries in North America
Exhibit 34: Europe – Market size and forecast 2018-2023 ($ millions)
Exhibit 35: Europe – Year-over-year growth 2019-2023 (%)
Exhibit 36: Top 3 countries in Europe
Exhibit 37: Asia – Market size and forecast 2018-2023 ($ millions)
Exhibit 38: Asia – Year-over-year growth 2019-2023 (%)
Exhibit 39: Top 3 countries in Asia
Exhibit 40: ROW – Market size and forecast 2018-2023 ($ millions)
Exhibit 41: ROW – Year-over-year growth 2019-2023 (%)
Exhibit 42: Top 3 countries in ROW
Exhibit 43: Key leading countries
Exhibit 44: Market opportunity
Exhibit 45: Impact of drivers and challenges
Exhibit 46: Vendor landscape
Exhibit 47: Landscape disruption
Exhibit 48: Vendors covered
Exhibit 49: Vendor classification
Exhibit 50: Market positioning of vendors
Exhibit 51: Bristol-Myers Squibb Company – Vendor overview
Exhibit 52: Bristol-Myers Squibb Company – Business segments
Exhibit 53: Bristol-Myers Squibb Company – Organizational developments
Exhibit 54: Bristol-Myers Squibb Company – Geographic focus
Exhibit 55: Bristol-Myers Squibb Company – Key offerings
Exhibit 56: Bristol-Myers Squibb Company – Key customers
Exhibit 57: F. Hoffmann-La Roche Ltd – Vendor overview
Exhibit 58: F. Hoffmann-La Roche Ltd – Business segments
Exhibit 59: F. Hoffmann-La Roche Ltd – Organizational developments
Exhibit 60: F. Hoffmann-La Roche Ltd – Geographic focus
Exhibit 61: F. Hoffmann-La Roche Ltd – Segment focus
Exhibit 62: F. Hoffmann-La Roche Ltd – Key offerings
Exhibit 63: F. Hoffmann-La Roche Ltd – Key customers
Exhibit 64: Johnson & Johnson Services, Inc. – Vendor overview
Exhibit 65: Johnson & Johnson Services, Inc. – Business segments
Exhibit 66: Johnson & Johnson Services, Inc. – Organizational developments
Exhibit 67: Johnson & Johnson Services, Inc. – Geographic focus
Exhibit 68: Johnson & Johnson Services, Inc. – Segment focus
Exhibit 69: Johnson & Johnson Services, Inc. – Key offerings
Exhibit 70: Johnson & Johnson Services, Inc. – Key customers
Exhibit 71: Novartis AG – Vendor overview
Exhibit 72: Novartis AG – Business segments
Exhibit 73: Novartis AG – Organizational developments
Exhibit 74: Novartis AG – Geographic focus
Exhibit 75: Novartis AG – Segment focus
Exhibit 76: Novartis AG – Key offerings
Exhibit 77: Novartis AG – Key customers
Exhibit 78: Takeda Pharmaceutical Company Limited – Vendor overview
Exhibit 79: Takeda Pharmaceutical Company Limited – Business segments
Exhibit 80: Takeda Pharmaceutical Company Limited – Organizational developments
Exhibit 81: Takeda Pharmaceutical Company Limited – Geographic focus
Exhibit 82: Takeda Pharmaceutical Company Limited – Key offerings
Exhibit 83: Takeda Pharmaceutical Company Limited – Key customers
Exhibit 84: Validation techniques employed for market sizing


【レポート販売概要】

■ タイトル:血液癌治療の世界市場2019-2023
■ 発行日:2019年2月26日
■ 調査会社:Technavio
■ 商品コード:IRTNTR30962
■ 調査対象地域:グローバル、アジア、北米、ヨーロッパ(EMEA)
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。